Canada markets closed

Allogene Therapeutics, Inc. (ALLO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.7700-0.2400 (-7.97%)
At close: 04:00PM EDT
2.8000 +0.03 (+1.08%)
After hours: 06:28PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-292,297
-327,265
-340,414
-182,051
-316,381
Depreciation & amortization
14,247
14,199
14,295
10,454
7,586
Deferred income taxes
-
-
-
0
0
Stock based compensation
59,105
65,951
83,600
80,818
65,261
Change in working capital
-27,168
-15,305
3,897
-31,949
53,922
Accounts Payable
-8,677
-7,502
4,868
-767
615
Other working capital
-227,482
-239,249
-225,710
-206,258
-181,051
Other non-cash items
323
579
2,329
-73,129
3,955
Net cash provided by operating activites
-226,993
-237,733
-220,519
-184,812
-115,093
Cash flows from investing activities
Investments in property, plant and equipment
-489
-1,516
-5,191
-21,446
-65,958
Acquisitions, net
-
0
0
-17,710
0
Purchases of investments
-484,666
-438,629
-248,109
-525,583
-1,037,591
Sales/Maturities of investments
557,642
603,434
359,459
728,394
598,426
Net cash used for investing activites
72,487
163,289
106,159
163,655
-505,123
Cash flows from financing activities
Common stock issued
-
91,112
0
0
621,933
Net cash used privided by (used for) financing activities
95,614
95,695
2,950
11,963
633,591
Net change in cash
-58,892
21,251
-111,410
-9,194
13,375
Cash at beginning of period
120,223
72,196
183,606
192,800
179,425
Cash at end of period
61,331
93,447
72,196
183,606
192,800
Free Cash Flow
Operating Cash Flow
-226,993
-237,733
-220,519
-184,812
-115,093
Capital Expenditure
-489
-1,516
-5,191
-21,446
-65,958
Free Cash Flow
-227,482
-239,249
-225,710
-206,258
-181,051